This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

The Leukemia & Lymphoma Society Research Symposium

October 11th, 2012

LLS Research Symposium:

"Targeted Therapies & Personalized Medicine" for Patients with Hematologic Malignancies

What: A cadre of leading researchers in hematology, oncology, cell biology, and biotechnology are conducting presentations and discussions at this symposium to review the latest advances in blood cancer research, including:

Ron Levy, MD, Stanford (9:15 a.m.)
Anthony G. Letai, MD, PhD, Dana-Farber Cancer Institute (10 a.m.)
Monica L. Guzman, PhD, Weill Cornell Medical College (9:30 a.m.)
Stephan A. Grupp, MD, PhD, Children's Hospital of Philadelphia (3:30 p.m.)
Larry W. Kwak, MD, PhD, MD Anderson Cancer Center (4 p.m.)
G. Steven Burrill, "biotech guru" (Keynote speaker and panelist) (1 p.m.)
Thomas O. Daniel, MD, Celgene (1 p.m. panel discussion)

Where: 5th Floor of the Westin New York (270 West 43rd Street)

When: Thursday October 18, 2012, 9 a.m. to 5 p.m.

Provided by The Leukemia & Lymphoma Society

Citation: The Leukemia & Lymphoma Society Research Symposium (2012, October 11) retrieved 4 August 2026 from https://sciencex.com/wire-news/111428554/the-leukemia-lymphoma-society-research-symposium.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.